ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,789,000 | +1267.2% | 30,003 | +903.1% | 0.00% | – |
| Q2 2021 | $204,000 | -58.6% | 2,991 | -53.4% | 0.00% | -100.0% |
| Q4 2020 | $493,000 | +13.1% | 6,417 | +10.1% | 0.00% | 0.0% |
| Q3 2020 | $436,000 | +17.8% | 5,828 | -0.9% | 0.00% | 0.0% |
| Q2 2020 | $370,000 | +38.6% | 5,878 | -7.5% | 0.00% | 0.0% |
| Q1 2020 | $267,000 | -5.3% | 6,357 | +2.4% | 0.00% | 0.0% |
| Q4 2019 | $282,000 | +1.4% | 6,206 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $278,000 | -6.7% | 6,066 | +19.4% | 0.00% | 0.0% |
| Q2 2019 | $298,000 | +25.7% | 5,081 | -3.9% | 0.00% | 0.0% |
| Q1 2019 | $237,000 | +9.7% | 5,285 | +12.8% | 0.00% | 0.0% |
| Q3 2018 | $216,000 | +5.9% | 4,685 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $204,000 | – | 4,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |